273 related articles for article (PubMed ID: 12923445)
1. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
[TBL] [Abstract][Full Text] [Related]
2. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.
Kaneko K; Wang Z; Kim SH; Morelli AE; Robbins PD; Thomson AW
Gene Ther; 2003 Jan; 10(2):143-52. PubMed ID: 12571643
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
5. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
Spriewald BM; Ensminger SM; Bushell A; Wood KJ
Transplantation; 2008 Dec; 86(11):1615-21. PubMed ID: 19077898
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
8. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
[TBL] [Abstract][Full Text] [Related]
9. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
Zahorchak AF; Kean LS; Tokita D; Turnquist HR; Abe M; Finke J; Hamby K; Rigby MR; Larsen CP; Thomson AW
Transplantation; 2007 Jul; 84(2):196-206. PubMed ID: 17667811
[TBL] [Abstract][Full Text] [Related]
10. Long-term limb allograft survival using anti-CD40L antibody in a murine model.
Tung TH; Mackinnon SE; Mohanakumar T
Transplantation; 2003 Mar; 75(5):644-50. PubMed ID: 12640303
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
12. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
[TBL] [Abstract][Full Text] [Related]
13. Hosts lacking fms-like tyrosine kinase 3 ligand exhibit marked reductions in transplant vascular sclerosis.
Wang Z; Taner T; Morelli AE; Thomson AW
Transplantation; 2005 Apr; 79(8):869-75. PubMed ID: 15849537
[TBL] [Abstract][Full Text] [Related]
14. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
Qian Y; Boisgerault F; Benichou G; Dana MR
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Jul; 80(2):255-63. PubMed ID: 16041272
[TBL] [Abstract][Full Text] [Related]
17. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
Cai Y; Zhou PJ; Tang XD
Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
[TBL] [Abstract][Full Text] [Related]
18. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
20. Control of intestinal allograft rejection by FTY720 and costimulation blockade.
Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW
Transplant Proc; 2005; 37(1):114-5. PubMed ID: 15808565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
